Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screens

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Multimodal soft tissue markers for bridging high-resolution diagnostic imaging with therapeutic intervention

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Mutations known from B-cell lymphoid malignancies are not found in CD34+ stem cells from patients with lymphoma

    Research output: Contribution to journalLetterResearchpeer-review

  2. TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Rui Lopes
  • Kathleen Sprouffske
  • Caibin Sheng
  • Esther C H Uijttewaal
  • Adriana Emma Wesdorp
  • Jan Dahinden
  • Simon Wengert
  • Juan Diaz-Miyar
  • Umut Yildiz
  • Melusine Bleu
  • Verena Apfel
  • Fanny Mermet-Meillon
  • Rok Krese
  • Mathias Eder
  • André Vidas Olsen
  • Philipp Hoppe
  • Judith Knehr
  • Walter Carbone
  • Rachel Cuttat
  • Annick Waldt
  • Marc Altorfer
  • Ulrike Naumann
  • Joachim Weischenfeldt
  • Antoine deWeck
  • Audrey Kauffmann
  • Guglielmo Roma
  • Dirk Schübeler
  • Giorgio G Galli
View graph of relations

Millions of putative transcriptional regulatory elements (TREs) have been cataloged in the human genome, yet their functional relevance in specific pathophysiological settings remains to be determined. This is critical to understand how oncogenic transcription factors (TFs) engage specific TREs to impose transcriptional programs underlying malignant phenotypes. Here, we combine cutting edge CRISPR screens and epigenomic profiling to functionally survey ≈15,000 TREs engaged by estrogen receptor (ER). We show that ER exerts its oncogenic role in breast cancer by engaging TREs enriched in GATA3, TFAP2C, and H3K27Ac signal. These TREs control critical downstream TFs, among which TFAP2C plays an essential role in ER-driven cell proliferation. Together, our work reveals novel insights into a critical oncogenic transcription program and provides a framework to map regulatory networks, enabling to dissect the function of the noncoding genome of cancer cells.

Original languageEnglish
Article numbereabf5733
JournalScience Advances
Volume7
Issue number27
DOIs
Publication statusPublished - Jul 2021

ID: 66549888